PCNA and neoplasm: In mice implanted with EB1089 pellets, average tumor volume decreased gradually over the four weeks of treatment.The treatment with EB1089 decreased PCNA protein expression. Both forms of administration of EB1089 showed to reduce tumor growth; however, the data suggested that pellet delivery may minimize the calcemic side effects.